Brain Canada Brain Canada
FR Donate

Our directory of funded grants

366 result(s) found

Development of a caregiver reported and weighted dementia outcome

Project Overview

Caregivers of people living with dementia know the person the best and have direct experience of how their partner’s dementia is progressing. Their experiences are pivotal in judging the real-world benefits of treatment and making decisions to keep the person at home or consider different levels o…

See researchers on this project
Principal Investigator:
  • Ayse Kuspinar, McMaster University

Development of a high throughput 3D microphysiologicalplatform for rapid automated assessment of human brain organoids response to drugs targeting neurological disorders

Project Overview

Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the most common and devastating neurological diseases, with over 750,000 AD patients and over 100,000 PD patients in Canada. Drug development remains a slow, expensive and inefficient process. The biopharmaceutical industries need alterna…

See researchers on this project
Principal Investigator:
  • Thomas Durcan, Montreal Neurological Institute and Hospital, McGill University
Team Members:
  • Edward Fon, McGill University
  • Margaret Magdesian, ANANDA Devices
  • Christopher Moraes, McGill University

Development of novel oligonucleotide delivery modalities for Huntington disease

Project Overview

Huntington disease (HD) is an inherited neurodegenerative disease that affects approximately 1 in 7500 individuals in the Western world. The cause of HD is a mutation in one copy of the HTT gene, which produces the toxic mutant huntingtin protein responsible for the brain cell loss associated with t…

See researchers on this project
Principal Investigator:
  • Blair Leavitt, University of British Columbia
Team Members:
  • Danica Stanimirovic, National Research Council of Canada
  • Abedelnasser Abulrob, National Research Council of Canada
  • Jodi McBride, Oregon Health and Science University

Developmental origins of stress and self-regulation and implications for interventions to improve childhood behavior

Project Overview

Dr.  Neuenschwander’s research aims to explore how exposure to stress during pregnancy affects children’s development, specifically in relation to children whose mothers were depressed and/or on antidepressants during pregnancy. She is examining whether or not these children have problems later…

See researchers on this project
Principal Investigator:
  • Regula Neuenschwander, Child & Family Research Institute

Direct microglial reprogramming to study Parkinson’s Disease

Project Overview

The human brain is a complex organ that presents many challenges for neuroscientists. For instance, tissue availability represents a major problem given that this organ does not regenerates, making it next to impossible to obtain live tissue from patients that would allow to study how cells in the b…

See researchers on this project
Principal Investigator:
  • Janelle Drouin-Ouellet, University of Montreal

Discovery of Therapeutic Targets for FUS- and TDP43-Dependent Forms of ALS

Project Overview

The four most commonly studied ALS proteins are SOD1, TDP-43, FUS and C9ORF72. Of these, TDP-43 and FUS have the most in common. Not only do they share similar functions inside cells, but in motor neurons of people with ALS, they both accumulate in clumps outside of the area where they are supposed …

See researchers on this project
Principal Investigator:
  • Peter St. George-Hyslop, University of Toronto
Team Members:
  • Mei Zhen, Lunenfeld-Tanenbaum Research Institute, Mount Sinani Hospital
  • Peter Roy, University of Toronto
  • Ben Wolozin, Boston University
  • Clemens Kaminski, University of Cambridge

Discovery of transcriptomic biomarkers and epigenetic therapeutic targets for c9ALS and sALS

Project Overview

Dr. Belzil began her research career as a PhD student at the Université de Montréal under the guidance of world renowned geneticist and Director of the Montreal Neurological Institute and Hospital, Dr. Guy Rouleau. During this time, Dr. Belzil pursued a better understanding of the genetics behind …

See researchers on this project
Principal Investigator:
  • Veronique Belzil, Mayo Clinic

Disrupted SUMOylation facilitates rogue TDP-43 in ALS

Project Overview

Proteins are large molecules that play many essential roles in the body. They do most of the work inside cells and are necessary for the structure, function and regulation of all tissues and organs. TDP-43 is a protein that is usually found inside the cell nucleus. However, in most people with ALS, …

See researchers on this project
Principal Investigator:
  • Terry Suk, University of Ottawa

Dissecting acetylcholine/glutamate co-transmission in the striatum: importance of individual neurotransmitter in addiction and movement disorders

Project Overview

Parkinson’s disease and addiction have tremendous human and economical costs for our society. The secret to understand these pathologies lies in unravelling the functioning of a specific brain region named striatum. The striatum regulates several behavioural outputs that are affected in Parkinson…

See researchers on this project
Principal Investigator:
  • Salah El Mestikawy, Douglas Mental Health University Institute
Team Members:
  • Vania Prado, University of Western Ontario
  • Marco Prado, University of Western Ontario

Distinct neuro-immune interactions drive sex differences  in chronic pain

Project Overview

One of the most important advances in our understanding of chronic pain over the last decade or so is the realization that neurons are not the only cells in the central nervous system participating in the processing of pain signals. Immune-like “glial” cells (especially microglia and astrocytes)…

See researchers on this project
Principal Investigator:
  • Jeffrey Mogil, McGill University
Team Members:
  • Michael Salter, The Hospital for Sick Children
  • Yves De Koninck, Université Laval
  • Jason Lerch, University of Toronto

DNA methylation signatures in a rat model of Fetal Alcohol Spectrum Disorder

Project Overview

Prenatal alcohol exposure can result in abnormal brain development, causing Fetal Alcohol Spectrum Disorder (FASD), which is linked to a number of cognitive, behavioural, and immune deficits that last across the lifetime. Although the lasting effects of alcohol on development are well studied, the m…

See researchers on this project
Principal Investigator:
  • Alexandre Lussier, University of British Columbia

Does rehabilitation improve brain structure/function and motor outcomes of children with developmental coordination disorder?

Project Overview

Ms. Izadi-Najafabadi’s research focuses on the effect of Cognitive Orientation to Occupational Performance (CO-OP)—the current best-practiced intervention for children with Developmental Coordination Disorder (DCD)—on their structural and functional brain connectivity. This study also explores…

See researchers on this project
Principal Investigator:
  • Sara Izadi-Najafabadi, Brain Research Centre, University of British Columbia

Dopaminergic modulation of stroke recovery

Project Overview

Strokes often cause brain damage that affects normal cognitive and sensorimotor functions. The brain has the extraordinary ability to adapt by forming new circuits which can, to some extent, compensate for neuronal loss. The recovery of motor function can be improved by rehabilitation exercises aime…

See researchers on this project
Principal Investigator:
  • Christian Ethier, Université Laval

Douglas-Bell Canada Brain Bank, an essential platform for brain research in Canada

Project Overview

The Douglas-Bell Canada Brain Bank (DBCBB) houses and manages over 3,000 brains, as well as a large relational database containing demographic, clinical and developmental histories from the donors. The DBCBB is one of the rare brain banks in the world to collect brains from people who suffered from …

See researchers on this project
Principal Investigator:
  • Gustavo Turecki, Douglas Hospital Research Centre
Team Members:
  • Naguib Mechawar, Douglas Mental Health University Institute
  • Michael J. Meaney, Douglas Mental Health University Institute
  • Guy Rouleau, Montreal Neurological Hospital and Institute
  • Michael Kobor, University of British Columbia
  • Martin Alda, Dalhousie University
  • Paul R. Albert, Ottawa Hospital Research Institute
  • Cathy Barr, Toronto Western Hospital
  • Darrell Mousseau, University of Saskatchewan
  • Satyabrata Kar, University of Alberta
  • Shimon Amir, Concordia University
  • Ana Andreazza, Centre for Addiction and Mental Health
  • Gilbert Bernier, Research Centre, Maisonneuve-Rosemont Hospital
  • Diane Boivin, Douglas Mental Health University Institute
  • Bernard Brais, Montreal Neurological Hospital and Institute
  • Nicolas Cermakian, Douglas Mental Health University Institute
  • Balu Chakravarthy, Carleton University
  • Cletus D’Souza, BC Cancer Agency
  • Salah El Mestikawy, Douglas Mental Health University Institute
  • Carl Ernst, Douglas Mental Health University Institute
  • Ken Evans, Queen's University
  • Harriet Feilotter, Queen's University
  • Nicolas Flamand, Institut Universitaire de Cardiologie et Pneumologie de Quebec, Laval University
  • Cecilia Flores, Douglas Mental Health University Institute
  • David Fortin, Université de Sherbrooke
  • Edith Hamel, Montreal Neurological Hospital and Institute
  • Michael R. Hayden, University of British Columbia
  • Sébastien Hébert, CHUQ Research Centre, Laval University
  • Martin Hirst, BC Cancer Agency
  • Jack Jhamandas, University of Alberta
  • Sidney H. Kennedy, University Health Network
  • Christine Lavoie, Université de Sherbrooke
  • Marco Marra, BC Cancer Agency
  • Anne McKinney, McGill University
  • Daniel Mueller, Centre for Addiction and Mental Health
  • Gerhard Multhaup, McGill University
  • Lisa Münter, McGill University
  • Art Petronis, University of Toronto/CAMH
  • Bruce Pike, Montreal Neurological Hospital and Institute
  • Judes Poirier, Douglas Mental Health University Institute
  • Alexandre Prat, CHUM Research Centre, University of Montréal
  • Rémi Quirion, Douglas Mental Health University Institute
  • Pedro Rosa-Neto, Douglas Mental Health University Institute
  • Xavier Roucou, Université de Sherbrooke
  • Elizabeth Simpson, University of British Columbia
  • Abbas Sadikot, Montreal Neurological Hospital and Institute
  • Lalit Srivastava, Douglas Mental Health University Institute
  • Moshe Szyf, McGill University
  • Derek van der Kooy, University of Toronto
  • Christine Vande Velde, Université de Montréal
  • Lan Xiong, CHUM Research Centre, University of Montréal
  • L. Trevor Young, Centre for Addiction and Mental Health

Drug Delivery across the Human Blood-Brain Barrier

Project Overview

Toxic amyloid proteins are known to be a significant contributing factor in the development of Alzheimer’s disease. Abnormal clusters of protein fragments build up between nerve cells in the brainleading to impaired memory. The most important therapies in development currently are biologics, antib…

See researchers on this project
Principal Investigator:
  • Nathan Yoganathan, KalGene Pharmaceuticals Inc
Team Members:
  • Louis Collins, McGill University
  • Jean-Paul Soucy, McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University
  • Danica Stanimirovic, National Research Council of Canada
  • Balu Chakravarthy, Carleton University
  • Pedro Rosa-Neto, Douglas Mental Health University Institute

Drug repurposing in medulloblastoma using integrated functional genomic, epigenomic, and transcriptomic approaches

Project Overview

The project conducted by Dr. Gendoo is focused upon identifying potential therapeutic targets against Medulloblastoma (MB) subtypes. Identification of subtype-specific therapies is contingent upon: 1) proper classification of samples into MB subtypes; and 2) proper understanding of the pharmacologic…

See researchers on this project
Principal Investigator:
  • Deena Gendoo, The Hospital For Sick Children

Dysregulation of integrated stress response (ISR) pathway in Fragile X syndrome and autism

Project Overview

This project is focused on role of the integrated stress response (ISR) pathway in fragile X syndrome as well as autism.  Mehdi Hooshmandi is aiming to figure out the exact ISR pathway abnormalities in different cell types and regions of the brain. Once the altered molecule(s) is identified, it wil…

See researchers on this project
Principal Investigator:
  • Mehdi Hooshmandi, McGill University

Early Brain Development Following Prenatal Exposure to SSRI Antidepressants and Maternal Depression

Project Overview

Many women experience depression during pregnancy, and are often faced with challenging decisions surrounding antidepressant use during this critical time for their developing child. Fetal exposure to maternal antidepressant use is poorly understood, and further, the effects are often lef…

See researchers on this project
Principal Investigator:
  • Kayleigh Campbell, BCCHR

Early diagnosis of gliomas by using a novel multiplexed serum proteomic technology

Project Overview

Need for project: Gliomas are among the most malignant tumors, with very poor survival rates. Early diagnosis is highly desirable since it can facilitate more effective treatments of small tumors, which have not as yet extensively metastasized. It is thus of upmost importance to find non-invasive bi…

See researchers on this project
Principal Investigator:
  • Eleftherios Diamandis, Lunenfeld-Tanenbaum Research Institute
Team Members:
  • Douglas Fraser, Children’s Health Research Institute
  • Maxime Richer, Université de Sherbrooke

Early Postnatal Metabolic Treatment for the Fetal Alcohol Syndrome

Project Overview

Fetal Alcohol Syndrome (FAS) is the result of in utero alcohol exposure and is characterized by central nervous system developmental impairments which causes lifelong physical and cognitive disabilities. The mechanisms of the impaired brain development are poorly understood, but they seem to be rela…

See researchers on this project
Principal Investigator:
  • Paolo Bazzigaluppi, Toronto Western Hospital